The UK’s pharma industry has welcomed Theresa May's hard won agreement with EU leaders on Brexit, which is already threatened by intense political infighting.
Australia’s Senate has passed a motion calling on the government to extend an opt-out period for its controversial My Health Record scheme, which has been dogged by concerns about privacy.<
The liberty cap mushroom, notoriously used illegally as a psychoactive drug, could be the inspiration for a new therapy for depression according to the US drug regulator.
The UK's regulator has granted new licences to a hub of biotech companies to allow them to continue manufacturing of groundbreaking gene and cell therapies at an innovative purpose-built ce
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.